Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries G1 Therapeutics Inc (NQ: GTHX ) 7.150 UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about G1 Therapeutics Inc < Previous 1 2 3 4 5 6 Next > 12 Health Care Stocks Moving In Monday's Intraday Session December 11, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 07, 2023 Via Benzinga G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer Therapy December 05, 2023 From G1 Therapeutics Via GlobeNewswire G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium November 29, 2023 From G1 Therapeutics Via GlobeNewswire Earnings Preview For G1 Therapeutics October 31, 2023 Via Benzinga Analyst Ratings for G1 Therapeutics October 06, 2023 Via Benzinga Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 01, 2023 Gainers Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session November 01, 2023 Via Benzinga Analyst Ratings for G1 Therapeutics August 03, 2023 Via Benzinga Where G1 Therapeutics Stands With Analysts June 26, 2023 Via Benzinga Recap: G1 Therapeutics Q1 Earnings May 03, 2023 Via Benzinga Earnings Preview: G1 Therapeutics May 02, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 01, 2023 Via Benzinga G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights November 01, 2023 From G1 Therapeutics Via GlobeNewswire G1 Therapeutics’ COSELA® (trilaciclib) Recommended in Updated Small Cell Lung Cancer Guidelines from the American Society of Clinical Oncology (ASCO) October 18, 2023 From G1 Therapeutics Via GlobeNewswire Real World Data Indicate That Trilaciclib Reduces Hospitalizations and Myelosuppressive Events and May Improve Survival in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) October 27, 2023 Multiple Analyses Also Describe Significant Burden of Chemotherapy-Induced Myelosuppression and Impact on Healthcare Resource Utilization in ES-SCLC From G1 Therapeutics Via GlobeNewswire G1 Therapeutics Announces Upcoming Presentations at the 2023 ASCO Quality Care Symposium October 16, 2023 From G1 Therapeutics Via GlobeNewswire Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session October 19, 2023 Gainers Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 21, 2023 Via Benzinga Black Diamond Therapeutics Announces CEO Transition September 18, 2023 From Black Diamond Therapeutics, Inc Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 October 06, 2023 Via Benzinga G1 Therapeutics Provides Second Quarter 2023 Financial Results and Operational Highlights August 02, 2023 From G1 Therapeutics Via GlobeNewswire New Publication Highlights Real World Impact of Trilaciclib on Myelosuppressive Events in Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC) July 31, 2023 From G1 Therapeutics Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday July 28, 2023 Friday's session saw 59 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday July 21, 2023 On Friday, 54 companies hit new 52-week lows. Via Benzinga Trilaciclib Increases Pool of Memory T Cells in the Tumor Microenvironment Responsible for Long Term Immune Surveillance and Efficacy June 04, 2023 From G1 Therapeutics Via GlobeNewswire New Study Confirms Consistent Risk of Myelosuppression Across All Patients Receiving Chemotherapy for Small Cell Lung Cancer May 16, 2023 Real-World Data Show No Association Between Patient Characteristics and Risk of Myelosuppressive Events From G1 Therapeutics Via GlobeNewswire New Results from Phase 2 Trial Confirm Benefit of Trilaciclib in Reducing Adverse Events Related to an Antibody Drug Conjugate (ADC) May 10, 2023 From G1 Therapeutics Via GlobeNewswire Benzinga Pro's Top 5 Stocks To Watch For Tuesday, May 9, 2023: BABA, TSM, LCID, H, GTHX May 09, 2023 Alibaba (BABA) - China's most economically-important companies will be in focus this week ahead of earnings out of the nation's second largest ecommerce company behind Alibaba, JD.com (JD). Via Benzinga G1 Therapeutics Provides First Quarter 2023 Financial Results and Operational Highlights May 03, 2023 From G1 Therapeutics Via GlobeNewswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
